Log In
Print
BCIQ
Print
Print this Print this
 

Qinprezo (vosaroxin) (AG-7352) (formerly SNS-595, voreloxin)

Also known as: formerly SPC-595

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionQuinolone derivative that intercalates DNA and inhibits topoisomerase II (TOP2)
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today